Compare ESP & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESP | STIM |
|---|---|---|
| Founded | 1928 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.8M | 136.3M |
| IPO Year | N/A | 2018 |
| Metric | ESP | STIM |
|---|---|---|
| Price | $42.53 | $1.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 13.6K | ★ 2.1M |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | ★ 28.72 | N/A |
| EPS | ★ 3.16 | N/A |
| Revenue | $42,600,530.00 | ★ $129,873,000.00 |
| Revenue This Year | $9.16 | $101.67 |
| Revenue Next Year | $5.68 | $10.87 |
| P/E Ratio | $13.45 | ★ N/A |
| Revenue Growth | 4.90 | ★ 78.61 |
| 52 Week Low | $24.85 | $1.00 |
| 52 Week High | $55.00 | $5.92 |
| Indicator | ESP | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 71.26 | 30.82 |
| Support Level | $38.07 | $1.28 |
| Resistance Level | $39.84 | $1.51 |
| Average True Range (ATR) | 1.41 | 0.18 |
| MACD | 0.49 | 0.02 |
| Stochastic Oscillator | 88.45 | 12.82 |
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.